Templeton J S
Rheumatol Rehabil. 1978 Nov;17(4):219-21. doi: 10.1093/rheumatology/17.4.219.
Renal concentrating ability was measured in two groups of arthritic patients. The first had received long-term therapy with azapropazone and the second with other nonsteroidal anti-inflammatory drugs. Even after long periods of treatment, azapropazone did not adversely affect renal concentrating ability.
对两组关节炎患者的肾脏浓缩能力进行了测量。第一组长期接受阿扎丙宗治疗,第二组接受其他非甾体抗炎药治疗。即使经过长时间治疗,阿扎丙宗对肾脏浓缩能力也没有不利影响。